Department of Neurology, University of Ulm, Ulm, Germany.
Clinical Neuroanatomy, Department of Neurology, University of Ulm, Ulm, Germany.
Sci Rep. 2018 Oct 18;8(1):15389. doi: 10.1038/s41598-018-33830-z.
A sequential transaxonal disease spread of amyotrophic lateral sclerosis (ALS)-associated TDP-43 pathology in four stages has been defined by post-mortem data, which have been transferred to in vivo imaging by diffusion tensor imaging (DTI) studies. Here, we aimed to investigate whether DTI meta-data are consistent with this proposed pattern of progression in ALS. A systematic literature search using the search engines PubMed and Scopus yielded a total of 370 publications. Of these, 57 studies with cross-sectional data and 10 longitudinal studies of human whole-brain analyses of fractional anisotropy (FA) were included in the final data analysis. Statistical meta-analyses on coordinates of significant FA alterations were performed on a grand average alteration data set using a fixed-effect model. A widespread pattern of white matter impairment was identified from cross-sectional meta data (n = 2064 ALS patients vs. n = 1688 controls) and supported from longitudinal meta data (n = 266 ALS patients over 8 months). The results from cross-sectional meta-analyses corresponded to the brain regions and tract systems according to the sequential disease spread of ALS. Structural alterations in ALS patients vs. controls followed a power gradient, i.e., the most frequent alterations were observed along the corticospinal tract (CST, related to ALS stage 1), followed by frequent alterations along the corticorubral/-pontine tract (related to ALS stage 2), together with corticostriatal pathways (related to ALS stage 3), and, finally, alterations in the hippocampal regions adjacent to the proximal portion of the perforant path (related to ALS stage 4). The results from the DTI-based neuroimaging meta-analysis strongly support the model of the corticoefferent axonal disease progression in ALS and provides further in vivo evidence for the proposed staging scheme of ALS-associated pathology.
一项通过死后数据定义的、连续的跨神经元疾病传播模式将肌萎缩侧索硬化症(ALS)相关 TDP-43 病理学分为 4 个阶段,该模式已通过弥散张量成像(DTI)研究转移到体内成像。在这里,我们旨在研究 DTI 元数据是否与 ALS 中提出的这种进展模式一致。使用搜索引擎 PubMed 和 Scopus 进行了系统的文献搜索,共产生了 370 篇出版物。其中,纳入了 57 项具有横断面数据的研究和 10 项关于人类全脑各向异性分数(FA)的纵向研究进行最终数据分析。使用固定效应模型,在平均变化数据集上对显著 FA 改变的坐标进行了统计元分析。从横断面元数据分析(n=2064 名 ALS 患者与 n=1688 名对照)中确定了广泛的白质损伤模式,并从纵向元数据分析(n=266 名 ALS 患者在 8 个月内)中得到了支持。横断面元分析的结果与 ALS 连续疾病传播的大脑区域和束系统相对应。ALS 患者与对照之间的结构改变遵循幂梯度,即最常见的改变沿皮质脊髓束(CST,与 ALS 阶段 1 相关)观察到,其次是沿皮质红核/桥脑束(与 ALS 阶段 2 相关),以及皮质纹状体通路(与 ALS 阶段 3 相关),最后是与内嗅皮质区相邻的海马区域的改变(与 ALS 阶段 4 相关)。基于 DTI 的神经影像学元分析的结果强烈支持 ALS 中皮质传出轴突疾病进展的模型,并为 ALS 相关病理学的提出分期方案提供了进一步的体内证据。